nach oben

Erschienen in:

14.04.2016 | Review Paper

Psychological Distress, Anxiety, and Depression of Cancer-Affected BRCA1/2 Mutation Carriers: a Systematic Review

verfasst von: Johanna Ringwald, Christina Wochnowski, Kristin Bosse, Katrin Elisabeth Giel, Norbert Schäffeler, Stephan Zipfel, Martin Teufel

Erschienen in: Journal of Genetic Counseling | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Abstract

Understanding the intermediate- and long-term psychological consequences of genetic testing for cancer patients has led to encouraging research, but a clear consensus of the psychosocial impact and clinical routine for cancer-affected BRCA1 and BRCA2 mutation carriers is still missing. We performed a systematic review of intermediate- and long-term studies investigating the psychological impact like psychological distress, anxiety, and depression in cancer-affected BRCA mutation carriers compared to unaffected mutation carriers. This review included the screening of 1243 studies. Eight intermediate- and long-term studies focusing on distress, anxiety, and depression symptoms among cancer-affected mutation carriers at least six months after the disclosure of genetic testing results were included. Studies reported a great variety of designs, methods, and patient outcomes. We found evidence indicating that cancer-affected mutation carriers experienced a negative effect in relation to psychological well-being in terms of an increase in symptoms of distress, anxiety, and depression in the first months after test disclosure. In the intermediate- and long-term, no significant clinical relevant symptoms occurred. However, none of the included studies used specific measurements, which can clearly identify psychological burdens of cancer-affected mutation carriers. We concluded that current well-implemented distress screening instruments are not sufficient for precisely identifying the psychological burden of genetic testing. Therefore, future studies should implement coping strategies, specific personality structures, the impact of genetic testing, supportive care needs and disease management behaviour to clearly screen for the possible intermediate- and long-term psychological impact of a positive test disclosure.

Ardern-jones, A., Kenen, R., & Eeles, R. (2005). Too much, too soon? patients and health professionals’ views concerning the impact of genetic testing at the time of breast cancer diagnosis in women under the age of 40. European Journal of Cancer Care, 14(3), 272–281.CrossRefPubMed

Beran, T. M., Stanton, A. L., Kwan, L., Seldon, J., Bower, J. E., Vodermaier, A., et al. (2008). The trajectory of psychological impact in brca1/2 genetic testing: does time heal? Annals of Behavioral Medicine, 36(2), 107–116.CrossRefPubMed

Bonadona, V., Saltel, P., Desseigne, F., Mignotte, H., Saurin, J.-C., Wang, Q., et al. (2002). Cancer patients who experienced diagnostic genetic testing for cancer susceptibility reactions and behavior after the disclosure of a positive test result. Cancer Epidemiology, Biomarkers & Prevention, 11(1), 97–104.

Bosch, N., Junyent, N., Gadea, N., Brunet, J., Ramon y Cajal, T., Torres, A., et al. (2012). What factors may influence psychological well being at three months and one year post brca genetic result disclosure? Breast, 21(6), 755–760.

Brunstrom, K., Murray, A., & McAllister, M. (2015). Experiences of women who underwent predictive BRCA 1/2 mutation testing before the age of 30. Journal of Genetic Counseling, 25(1), 90–100. doi:10.1007/s10897-015-9845-5.CrossRefPubMed

Carpenter, Kristen M., Eisenberg, Stacy, Weltfreid, Sharone, Low, Carissa A., Beran, Tammy, & Stanton, Annette L. (2013). Characterizing biased cancer-related cognitive processing: relationships with BRCA1/2 genetic mutation status, personal cancer history, age, and prophylactic surgery. Health Psychology.

Christinat, A., & Pagani, O. (2013). Practical aspects of genetic counseling in breast cancer: lights and shadows. Breast, 22(4), 375–382.CrossRefPubMed

Claes, E., Evers-Kiebooms, G., Boogaerts, A., Decruyenaere, M., Denayer, L., & Legius, E. (2004). Diagnostic genetic testing for hereditary breast and ovarian cancer in cancer patients: women's looking back on the pre-test period and a psychological evaluation. Genetic Testing, 8(1), 13–21.CrossRefPubMed

Crotser, C. B., & Boehmke, M. (2009). Survivorship considerations in adults with hereditary breast and ovarian cancer syndrome: state of the science. Journal of Cancer Survivorship, 3(1), 21–42.CrossRefPubMed

Croyle, R. T., Smith, K. R., Botkin, J. R., Baty, B., & Nash, J. (1997). Psychological responses to BRCA1 mutation testing: preliminary findings. Health Psychology, 16(1), 63.CrossRefPubMed

Cukier, Y. R., Thompson, H. S., Sussner, K., Forman, A., Jandorf, L., Edwards, T., et al. (2013). Factors associated with psychological distress among women of african descent at high risk for BRCA mutations. Journal of Genetic Counseling, 22(1), 101–107.CrossRefPubMed

de Souza, A. N., Groleau, D., Loiselle, C. G., Foulkes, W. D., & Wong, N. (2014). Cultural aspects of healthy brca carriers from two ethnocultural groups. Qualitative Health Research, 24(5), 665–681. doi:10.1177/1049732314528756.CrossRef

Douglas, H. A., Hamilton, R. J., & Grubs, R. E. (2009). The Effect of BRCA Gene Testing on Family Relationships: a Thematic Analysis of Qualitative Interviews. Journal of Genetic Counseling, 18(5), 418–435.CrossRefPubMed

Easton, D. F., Bishop, D. T., Ford, D., & Crockford, G. P. (1993). Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. American Journal of Human Genetics, 52(4), 678.PubMedPubMedCentral

Easton, D. F., Ford, D., & Bishop, D. T. (1995). Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. American Journal of Human Genetics, 56(1), 265.PubMedPubMedCentral

Eijzenga, W., Aaronson, N. K., Hahn, D. E. E., Sidharta, G. N., van der Kolk, L. E., Velthuizen, M. E., et al. (2014a). Effect of Routine Assessment of Specific Psychosocial Problems on Personalized Communication, Counselors' Awareness, and Distress Levels in Cancer Genetic Counseling Practice: A Randomized Controlled Trial. Journal of Clinical Oncology, 32(27), 2998–3004.CrossRefPubMed

Eijzenga, W., Bleiker, E. M. A., Hahn, D. E. E., Kluijt, I., Sidharta, G. N., Gundy, C., et al. (2014b). Psychosocial aspects of hereditary cancer (PAHC) questionnaire: development and testing of a screening questionnaire for use in clinical cancer genetics. Psycho-Oncology, 23(8), 862–869.CrossRefPubMed

Farrelly, A., White, V., Meiser, B., Jefford, M., Young, M.-A., Ieropoli, S., et al. (2013). Unmet support needs and distress among women with a BRCA1/2 mutation. Familial Cancer, 12(3), 509–518.CrossRefPubMed

Ford, D., Easton, D. F., Bishop, D. T., Narod, S. A., & Goldgar, D. E. (1994). Risks of cancer in BRCA1-mutation carriers. The Lancet, 343(8899), 692–695.CrossRef

Graves, K. D., Vegella, P., Poggi, E. A., Peshkin, B. N., Tong, A., Isaacs, C., et al. (2012). Long-term psychosocial outcomes of BRCA1/BRCA2 testing: differences across affected status and risk-reducing surgery choice. Cancer Epidemiology, Biomarkers & Prevention, 21(3), 445–455.CrossRef

Halbert, C. H., Stopfer, J. E., McDonald, J., Weathers, B., Collier, A., Troxel, A. B., et al. (2011). Long-term reactions to genetic testing for BRCA1 and BRCA2 mutations: does time heal women's concerns? Journal of Clinical Oncology, 29(32), 4302–4306.CrossRefPubMedPubMedCentral

Hallowell, N., Foster, C., Ardern-Jones, A., Eeles, R., Murday, V., & Watson, M. (2002). Genetic testing for women previously diagnosed with breast/ovarian cancer: examining the impact of BRCA1 and BRCA2 mutation searching. Genetic Testing, 6(2), 79–87.CrossRefPubMed

Hallowell, N., Foster, C., Eeles, R., Ardern-Jones, A., & Watson, M. (2004). Accommodating risk: responses to BRCA1/2 genetic testing of women who have had cancer. Social Science & Medicine, 59(3), 553–565.CrossRef

Hamilton, J. G., Lobel, M., & Moyer, A. (2009). Emotional distress following genetic testing for hereditary breast and ovarian cancer: a meta-analytic review. Health Psychology, 28(4), 510–518.CrossRefPubMedPubMedCentral

Hampel, Heather, Bennett, Robin L, Buchanan, Adam, Pearlman, Rachel, & Wiesner, Georgia L. (2014). A practice guideline from the American College Of Medical Genetics And Genomics and the National Society Of Genetic Counselors: referral indications for cancer predisposition assessment. Genetics in Medicine.

Heshka, J. T., Palleschi, C., Howley, H., Wilson, B., & Wells, P. S. (2008). A systematic review of perceived risks, psychological and behavioral impacts of genetic testing. Genetics in Medicine, 10(1), 19–32.CrossRefPubMed

Hilgart, J. S., Coles, B., & Iredale, R. (2012). Cancer genetic risk assessment for individuals at risk of familial breast cancer. Cochrane Database of Systematic Reviews, 2, CD003721. doi:10.1002/14651858.CD003721.pub3.PubMed

Liberati, A., Altman, D. G., Tetzlaff, J., Cynthia, M., Gøtzsche, P. C., Ioannidis, J. P. A., et al. (2009). The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Annals of Internal Medicine, 151(4), W-65–W-94.CrossRef

Linden, W., Vodermaier, A., MacKenzie, R., & Greig, D. (2012). Anxiety and depression after cancer diagnosis: prevalence rates by cancer type, gender, and age. Journal of Affective Disorders, 141(2), 343–351.CrossRefPubMed

Low, C. A., Bower, J. E., Kwan, L., & Seldon, J. (2008). Benefit finding in response to BRCA1/2 testing. Annals of Behavioral Medicine, 35(1), 61–69.CrossRefPubMed

MacDonald, D. J., Sarna, L., Weitzel, J. N., & Ferrell, B. (2010). Women’s perceptions of the personal and family impact of genetic cancer risk assessment: focus group findings. Journal of Genetic Counseling, 19(2), 148–160.CrossRefPubMed

Mehnert, A., Brähler, E., Faller, H., Härter, M., Keller, M., Schulz, H., et al. (2014). Four-week prevalence of mental disorders in patients with cancer across major tumor entities. Journal of Clinical Oncology. doi:10.1200/JCO.2014.56.0086.PubMed

Meiser, B. (2005). Psychological impact of genetic testing for cancer susceptibility: an update of the literature. Psycho-Oncology, 14(12), 1060–1074.CrossRefPubMed

Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., et al. (1994). A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science, 266(5182), 66–71.CrossRefPubMed

Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Annals of Internal Medicine, 151(4), 264–269.CrossRefPubMed

Nelson, H. D., Pappas, M., Zakher, B., Mitchell, J. P., Okinaka-Hu, L., & Fu, R. (2014). Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the US Preventive Services Task Force recommendation. Annals of Internal Medicine, 160(4), 255–266.CrossRefPubMed

Newman, B., Austin, M. A., Lee, M., & King, M.-C. (1988). Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families. Proceedings of the National Academy of Sciences, 85(9), 3044–3048.CrossRef

Reichelt, J. G., Heimdal, K., Møller, P., & Dahl, A. A. (2004). BRCA1 testing with definitive results: a prospective study of psychological distress in a large clinic-based sample. Familial Cancer, 3(1), 21–28.CrossRefPubMed

Schlich-Bakker, K. J., ten Kroode, H. F. J., & Ausems, M. G. E. M. (2006). A literature review of the psychological impact of genetic testing on breast cancer patients. Patient Education and Counseling, 62(1), 13–20.CrossRefPubMed

Schlich-Bakker, K. J., Ausems, M. G. E. M., Schipper, M., ten Kroode, H. F. J., Wárlám-Rodenhuis, C. C., & van den Bout, J. (2008). BRCA1/2 mutation testing in breast cancer patients: a prospective study of the long-term psychological impact of approach during adjuvant radiotherapy. Breast Cancer Research and Treatment, 109(3), 507–514.CrossRefPubMed

Schmid-Büchi, S., Halfens, R. J. G., Dassen, T., Den Borne, V., & Bart (2008). A review of psychosocial needs of breast-cancer patients and their relatives. Journal of Clinical Nursing, 17(21), 2895–2909.CrossRefPubMed

Schwartz, M. D., Peshkin, B. N., Hughes, C., Main, D., Isaacs, C., & Lerman, C. (2002). Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample. Journal of Clinical Oncology, 20(2), 514–520.CrossRefPubMed

Smith, A. W., Dougall, A. L., Posluszny, D. M., Somers, T. J., Rubinstein, W. S., & Baum, A. (2008). Psychological distress and quality of life associated with genetic testing for breast cancer risk. Psycho-Oncology, 17(8), 767–773.CrossRefPubMed

Struewing, J. P., Hartge, P., Wacholder, S., Baker, S. M., Berlin, M., McAdams, M., et al. (1997). The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. New England Journal of Medicine, 336(20), 1401–1408.CrossRefPubMed

Tercyak, K. P., Lerman, C., Peshkin, B. N., Hughes, C., Main, D., Isaacs, C., et al. (2001). Effects of coping style and BRCA1 and BRCA2 test results on anxiety among women participating in genetic counseling and testing for breast and ovarian cancer risk. Health Psychology, 20(3), 217.CrossRefPubMed

van der Meer, L. B., van Duijn, E., Giltay, E. J., & Tibben, A. (2015). Do attachment style and emotion regulation strategies indicate distress in predictive testing? Journal of Genetic Counseling, 24(5), 862–871. doi:10.1007/s10897-015-9822-z.CrossRefPubMedPubMedCentral

van Dijk, S., Timmermans, D. R. M., Meijers-Heijboer, H., Tibben, A., van Asperen, C. J., & Otten, W. (2006). Clinical characteristics affect the impact of an uninformative DNA test result: the course of worry and distress experienced by women who apply for genetic testing for breast cancer. Journal of Clinical Oncology, 24(22), 3672–3677.CrossRefPubMed

van Oostrom, I., Meijers-Heijboer, H., Lodder, L. N., Duivenvoorden, H. J., van Gool, A. R., Seynaeve, C., et al. (2003). Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study. Journal of Clinical Oncology, 21(20), 3867–3874.CrossRefPubMed

Vansenne, F., Bossuyt, P. M. M., & de Borgie, C. A. J. M. (2009). Evaluating the psychological effects of genetic testing in symptomatic patients: a systematic Review. Genetic Testing and Molecular Biomarkers, 13(5), 555–563.CrossRefPubMed

Voorwinden, J. S., & Jaspers, J. P. C. (2015). Prognostic factors for distress after genetic testing for hereditary cancer. Journal of Genetic Counseling, 1–9. doi:10.1007/s10897-015-9894-9.

Vos, J., Menko, F. H., Oosterwijk, J. C., van Asperen, C. J., Stiggelbout, A. M., & Tibben, A. (2013a). Genetic counseling does not fulfill the counselees' need for certainty in hereditary breast/ovarian cancer families: an explorative assessment. Psycho-Oncology, 22(5), 1167–1176.CrossRefPubMed

Vos, J., van Asperen, C. J., Oosterwijk, J. C., Menko, F. H., Collee, M. J., Garcia, E. G., et al. (2013b). The counselees' self-reported request for psychological help in genetic counseling for hereditary breast/ovarian cancer: not only psychopathology matters. Psycho-Oncology, 22(4), 902–910.CrossRefPubMed

Walker, J., Hansen, C. H., Martin, P., Symeonides, S., Ramessur, R., Murray, G., et al. (2014). Prevalence, associations, and adequacy of treatment of major depression in patients with cancer: a cross-sectional analysis of routinely collected clinical data. The Lancet Psychiatry, 1(5), 343–350.CrossRefPubMed

Watson, M., Law, M. G., Santos, M. d., Greer, S., Baruch, J., & Bliss, J. (1994). The Mini-MAC: Further Development of the Mental Adjustment to Cancer Scale. Journal of Psychosocial Oncology, 12(3), 33–46.CrossRef

Wooster, R., Bignell, G., Lancaster, J., Swift, S., Seal, S., Mangion, J., et al. (1995). Identification of the Breast Cancer Susceptibility Gene BRCA2. Nature, 378(6559), 789–792.CrossRefPubMed

Zilliacus, E., Meiser, B., Gleeson, M., Watts, K., Tucker, K., Lobb, E. A., et al. (2012). Are we being overly cautious? a qualitative inquiry into the experiences and perceptions of treatment-focused germline BRCA genetic testing amongst women recently diagnosed with breast cancer. Support Care Cancer, 20(11), 2949–2958.CrossRefPubMed

Titel: Psychological Distress, Anxiety, and Depression of Cancer-Affected BRCA1/2 Mutation Carriers: a Systematic Review
verfasst von: Johanna Ringwald
Christina Wochnowski
Kristin Bosse
Katrin Elisabeth Giel
Norbert Schäffeler
Stephan Zipfel
Martin Teufel
Publikationsdatum: 14.04.2016
Verlag: Springer US
Erschienen in: Journal of Genetic Counseling / Ausgabe 5/2016
Print ISSN: 1059-7700
Elektronische ISSN: 1573-3599
DOI: https://doi.org/10.1007/s10897-016-9949-6

Neu im Fachgebiet Gynäkologie und Geburtshilfe

17.04.2024 | Postoperative nausea and vomiting | Nachrichten

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Psychological Distress, Anxiety, and Depression of Cancer-Affected BRCA1/2 Mutation Carriers: a Systematic Review

Abstract

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Hochrisiko-Eingriffe für postoperative Übelkeit

Adjuvante Brustkrebstherapie: Doppelt hält besser

Manche Gestagene können das Risiko für Meningeome erhöhen

Stillende Frauen haben geringeres kardiovaskuläres Risiko

Update Gynäkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2016

MTHFR: Addressing Genetic Counseling Dilemmas Using Evidence-Based Literature

Not the End of the Odyssey: Parental Perceptions of Whole Exome Sequencing (WES) in Pediatric Undiagnosed Disorders

The Role of Appearance in Adolescents’ Experiences of Neurofibromatosis Type 1: A Survey of Young People and Parents

Thank You to Reviewers

Impact of Genomic Counseling on Informed Decision-Making among ostensibly Healthy Individuals Seeking Personal Genome Sequencing: the HealthSeq Project

Family Communication and Cascade Testing for Fragile X Syndrome

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Hochrisiko-Eingriffe für postoperative Übelkeit

Adjuvante Brustkrebstherapie: Doppelt hält besser

Manche Gestagene können das Risiko für Meningeome erhöhen

Stillende Frauen haben geringeres kardiovaskuläres Risiko

Update Gynäkologie